These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 28664751)
1. The latest advances in the discovery of nitric oxide hybrid drug compounds. Serafim RAM; Pernichelle FG; Ferreira EI Expert Opin Drug Discov; 2017 Sep; 12(9):941-953. PubMed ID: 28664751 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide: state of the art in drug design. Serafim RA; Primi MC; Trossini GH; Ferreira EI Curr Med Chem; 2012; 19(3):386-405. PubMed ID: 22335514 [TBL] [Abstract][Full Text] [Related]
3. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies. Abdellatif KR; Chowdhury MA; Dong Y; Velázquez C; Das D; Suresh MR; Knaus EE Bioorg Med Chem; 2008 Nov; 16(22):9694-8. PubMed ID: 18930406 [TBL] [Abstract][Full Text] [Related]
4. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies. Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez C; Suresh MR; Knaus EE Bioorg Med Chem; 2009 Jul; 17(14):5182-8. PubMed ID: 19500994 [TBL] [Abstract][Full Text] [Related]
10. An introduction to NO-related therapeutic agents. Thatcher GR Curr Top Med Chem; 2005; 5(7):597-601. PubMed ID: 16101422 [TBL] [Abstract][Full Text] [Related]
11. Novel Structural Hybrids on the Base of Benzofuroxans and Furoxans. Mini-Review. Chugunova EA; Burilov AR Curr Top Med Chem; 2017; 17(9):986-1005. PubMed ID: 27697059 [TBL] [Abstract][Full Text] [Related]
12. Recent Developments in Drug Design of NO-donor Hybrid Compounds. Sharma R; Joubert J; Malan SF Mini Rev Med Chem; 2018; 18(14):1175-1198. PubMed ID: 29663881 [TBL] [Abstract][Full Text] [Related]
13. [Advances in the study of nitric oxide-donating drugs]. Zhang YH; Peng SX Yao Xue Xue Bao; 2009 Nov; 44(11):1200-10. PubMed ID: 21355319 [TBL] [Abstract][Full Text] [Related]
14. Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies. Velázquez CA; Chen QH; Citro ML; Keefer LK; Knaus EE J Med Chem; 2008 Mar; 51(6):1954-61. PubMed ID: 18314945 [TBL] [Abstract][Full Text] [Related]
15. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: synthesis, nitric oxide release studies and anti-inflammatory activities. Abdellatif KR; Chowdhury MA; Dong Y; Knaus EE Bioorg Med Chem; 2008 Jul; 16(13):6528-34. PubMed ID: 18513975 [TBL] [Abstract][Full Text] [Related]
16. Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease. Redington AE Eur J Pharmacol; 2006 Mar; 533(1-3):263-76. PubMed ID: 16466650 [TBL] [Abstract][Full Text] [Related]
17. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Mollace V; Muscoli C; Masini E; Cuzzocrea S; Salvemini D Pharmacol Rev; 2005 Jun; 57(2):217-52. PubMed ID: 15914468 [TBL] [Abstract][Full Text] [Related]
18. New Nitric Oxide Donors With Therapeutic Potential. Buca BR; Mititelu-Tarţau L; Lupuşoru RV; Popa GE; Rezuş C; Lupuşoru CE Rev Med Chir Soc Med Nat Iasi; 2016; 120(4):942-6. PubMed ID: 30141891 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological manipulation of nitric oxide levels in mouse follicle cultures demonstrates key role of extrafollicular control of ovulation. Mitchell LM; Kennedy CR; Hartshorne GM Hum Reprod; 2004 Aug; 19(8):1705-12. PubMed ID: 15229208 [TBL] [Abstract][Full Text] [Related]
20. Recent developments in the effects of nitric oxide-donating statins on cardiovascular disease through regulation of tetrahydrobiopterin and nitric oxide. Ma S; Ma CC Vascul Pharmacol; 2014 Nov; 63(2):63-70. PubMed ID: 25139660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]